Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
Renal Cell Carcinoma
RENAL CELL CARCINOMA ADVISOR
FEATURED CONTENT
-
-
Large Consortium Study Reveals More Details on the Link Between Viruses and Cancer
Researchers use whole-genome and whole-transcriptome sequencing data to reveal viral sequences in cancer tissue. -
“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection. -
Federal Ruling Puts Pressure on Clinical Trial Sponsors to Post Data
A federal ruling will force trial sponsors to post basic results on ClinicalTrials.gov, but it is unclear whether this is a feasible mandate. -
A New Trend in Drug Development: Leveraging Data from Expanded Access
Drug companies are gathering and including expanded access data in drug submissions as real-world data, but the purpose of expanded access was never for the purpose of research.
VIDEO SERIES
Tivozanib for RCC
Genitourinary Oncology: A Peek Over the Horizon
Immunotherapy of Renal Cell Carcinoma
Targeted Therapies for Renal Cell Carcinoma
Genetics and Heterogeneity
Genetic Predisposition to Kidney Cancers
Personalized Medicines for Kidney Cancers
Drugs in the Pipeline
Resistance to Therapy Among Kidney Cancers
Targeted Therapy
The Role of Neoadjuvant Tx
Sx Options – Ablative Techniques
Sx Options – Lymph Node
Sx Options – Cytoreductive Nephrectomy
TKIs – First-Line Therapy
TKIs – Second-Line Therapy
Biomarkers in RCC
The MET Pathway
Checkpoint Inhibitors
RENAL CELL CARCINOMA NEWS
CN for mRCC Does Not Up Survival in the Immune Checkpoint Inhibitor Era
Immune Checkpoint Inhibitors for mRCC Safe, Effective in a Real-World Setting
Preoperative Bone Metastases Not Prognostic in mRCC
Nivolumab Outperforms Everolimus in Advanced RCC, Study Confirms
Intermediate-Risk mRCC Patients Have Heterogeneous Survival Outcomes
Want to read more?
Please login or register first to view this content.
Next post in Renal Cell Carcinoma
